학술논문
Use of high-dimensional and spatial immune profiling to explore sotigalimab (CD40 agonist) activation of antigen presenting cells and T cells in the tumor microenvironment in patients with esophageal/gastroesophageal junction cancer.
Document Type
Article
Author
Source
Journal of Clinical Oncology; 2/1/2023 Supplement 1, Vol. 41, p450-450, 1p
Subject
Language
ISSN
0732183X